Arndt C - Search Results

1

Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy.

Gerullis H, Eimer C, Ecke TH, Georgas E, Arndt C, Otto T. Gerullis H, et al. Among authors: arndt c. Anticancer Drugs. 2013 Apr;24(4):422-5. doi: 10.1097/CAD.0b013e32835efe78. Anticancer Drugs. 2013. PMID: 23407060 Clinical Trial.

2

A phase II trial of temsirolimus in second-line metastatic urothelial cancer.

Gerullis H, Eimer C, Ecke TH, Georgas E, Freitas C, Kastenholz S, Arndt C, Heusch C, Otto T. Gerullis H, et al. Among authors: arndt c. Med Oncol. 2012 Dec;29(4):2870-6. doi: 10.1007/s12032-012-0216-x. Epub 2012 Mar 25. Med Oncol. 2012. PMID: 22447503 Clinical Trial.

3

Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance.

Gerullis H, Ecke TH, Janusch B, Arndt C, Heidari M, Oniani J, Otto T. Gerullis H, et al. Among authors: arndt c. Anticancer Drugs. 2011 Oct;22(9):940-3. doi: 10.1097/CAD.0b013e328347a86a. Anticancer Drugs. 2011. PMID: 21642839

4

Coating with autologous plasma improves biocompatibility of mesh grafts in vitro: development stage of a surgical innovation.

Gerullis H, Georgas E, Eimer C, Arndt C, Barski D, Lammers B, Klosterhalfen B, Borós M, Otto T. Gerullis H, et al. Among authors: arndt c. Biomed Res Int. 2013;2013:536814. doi: 10.1155/2013/536814. Epub 2013 Sep 17. Biomed Res Int. 2013. PMID: 24151608 Free PMC article.

5

Inflammatory reaction as determinant of foreign body reaction is an early and susceptible event after mesh implantation.

Gerullis H, Georgas E, Borós M, Klosterhalfen B, Eimer C, Arndt C, Otto S, Barski D, Ysebaert D, Ramon A, Otto T. Gerullis H, et al. Among authors: arndt c. Biomed Res Int. 2014;2014:510807. doi: 10.1155/2014/510807. Epub 2014 Mar 26. Biomed Res Int. 2014. PMID: 24783209 Free PMC article.

6

Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder Cancer.

Ecke TH, Arndt C, Stephan C, Hallmann S, Lux O, Otto T, Ruttloff J, Gerullis H. Ecke TH, et al. Among authors: arndt c. Anticancer Res. 2015 May;35(5):2651-5. Anticancer Res. 2015. PMID: 25964541

7

UBC^® Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study.

Ecke TH, Weiß S, Stephan C, Hallmann S, Arndt C, Barski D, Otto T, Gerullis H. Ecke TH, et al. Among authors: arndt c. Int J Mol Sci. 2018 Dec 2;19(12):3841. doi: 10.3390/ijms19123841. Int J Mol Sci. 2018. PMID: 30513851 Free PMC article.

8

Transvaginal PVDF-mesh for cystocele repair: A cohort study.

Barski D, Arndt C, Gerullis H, Yang J, Boros M, Otto T, Kolberg HC. Barski D, et al. Among authors: arndt c. Int J Surg. 2017 Mar;39:249-254. doi: 10.1016/j.ijsu.2017.02.006. Epub 2017 Feb 10. Int J Surg. 2017. PMID: 28192248 Free article.

9

Evaluation of a New Survivin ELISA and UBC^® Rapid for the Detection of Bladder Cancer in Urine.

Gleichenhagen J, Arndt C, Casjens S, Meinig C, Gerullis H, Raiko I, Brüning T, Ecke T, Johnen G. Gleichenhagen J, et al. Among authors: arndt c. Int J Mol Sci. 2018 Jan 11;19(1):226. doi: 10.3390/ijms19010226. Int J Mol Sci. 2018. PMID: 29324722 Free PMC article.

10

Exploring solid-phase proximity ligation assay for survivin detection in urine.

Gleichenhagen J, Arndt C, Casjens S, Töpfer C, Gerullis H, Raiko I, Taeger D, Ecke T, Brüning T, Johnen G. Gleichenhagen J, et al. Among authors: arndt c. PLoS One. 2022 Jun 29;17(6):e0270535. doi: 10.1371/journal.pone.0270535. eCollection 2022. PLoS One. 2022. PMID: 35767525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters